Skip to content

Author

Shuaiju Liu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

An Effector TaCRVP From Tuta Absoluta Oral Secretion Impairs H2O2‐Mediated Plant Defense by Targeting Tomato SlCAT2

ABSTRACT The arms race between plants and herbivorous insects involves sophisticated molecular strategies. While insects commonly secrete salivary effectors to modulate plant defenses, the underlying molecular mechanisms remain poorly characterized. In particular, as a devastating solanaceous pest, how Tuta absoluta, precisely subverts host immunity remains largely unknown. Here, we identify a novel salivary effector, the cysteine‐rich venom protein (TaCRVP), from the oral secretions (OSs) of T. absoluta. We reveal that TaCRVP is translocated into plant cells where it effectively hijacks host redox homeostasis by targeting the tomato catalase SlCAT2. Specifically, TaCRVP not only directly activates SlCAT2 H2O2‐scavenging capacity by promoting its tetramerization, but also blocks it from 26S proteasomal degradation by competitively inhibiting its interaction with the host E3 ubiquitin ligase SlAdBiL. Through this sophisticated dual mechanism, TaCRVP enhances SlCAT2 activity and stability to effectively suppress host H2O2 bursts, thereby subverting downstream jasmonic acid (JA) signaling and defensive metabolite production to facilitate insect feeding. Collectively, our results reveal a delicate evolutionary strategy whereby an insect effector hijacks the host SlCAT2‐SlAdBiL regulatory module, contributing to insect adaptation to host plants.

Jiang Yan, You-Dan Zhang, Zhuo Wang et al. · 0 citations
Review Aug 2026

Construction of cell factories, and multi-enzymatic and chemoenzymatic cascades to enable the efficient production of alkaloids.

Covering: up to 2025Alkaloids constitute an invaluable reservoir for pharmaceutical discovery. However, their therapeutic development has long been constrained by the inefficiencies of plant extraction, as well as the economic impracticality of total chemical synthesis. In recent years, biomanufacturing has emerged as a transformative paradigm, enabling sustainable and scalable access to these complex molecules. This review provides an overview of the pivotal advances in alkaloid biosynthesis, delineated across de novo biosynthesis in prokaryotic and eukaryotic systems, concise multi-enzyme cascades, and chemoenzymatic synthesis. By discussing these pioneering examples, analyzing the strategic lessons, inherent limitations, and corresponding solutions for these platforms, this review illuminates how synthetic biology and biocatalysis are collectively reshaping the landscape of alkaloid production and paving the way for their expanded pharmaceutical applications.

Zhenbo Yuan, Huiling Liu, Fei Li et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.